ExCellThera inc.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies (NCT04990323) | ExCellThera inc. | 2021-12-01 |
| US Phase I Study of ECT-001-CB in Patients With Sickle-Cell Disease (NCT04594031) | ExCellThera inc. | 2021-07-13 |
| US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia (NCT04103879) | ExCellThera inc. | 2020-11-13 |
Track ExCellThera inc. automatically
Every clearance here is in the API, with alerts when new ones post.